Published on Pfizer: the world's largest research-based pharmaceutical company (http://www.pfizer.com)

Home > Research > About R&D > R&D Locations > R&D Locations

R&D Locations

R&D Locations

Pfizer Global Research & Development has four major locations across the United States and England. While Pfizer colleagues at each center employ unique technologies to focus on site-specific functions and therapeutic areas, together they comprise an integrated global network of discovery and development. Global databases and streamlined distribution work to create a synergy of ideas, tools, and expertise that drive a robust pipeline and help Pfizer researchers and scientists create some of the most promising new medicines to help improve the health and wellness of people around the world.

Pfizer Research at La Jolla, San Diego, California

Site Statistics:

  • 33.5-acre campus with more than 1 million-square-feet of state-of-the-art facilities with specialized laboratories and equipment
  • Located in the San Diego area, which has one of the largest concentrations of academic and biotechnology institutions in the world

Functions: Biology, Chemistry, Pharmacokinetics & Drug Metabolism, Drug Safety, Pharmaceutical Sciences, Comparative Medicine, Immunology and Clinical Development

Primary Therapeutic Areas: Oncology and Vaccines

Key Technologies: Structural and Computational Biology, Medicinal Chemistry (Computational Analysis and Molecular Design, Gene-To-Protein Crystal Structure Capability for Structure Based Drug Design Platform); Analytical Chemistry (Proteomics and NMR Protein Structure and Fragment Screening); Parallel Protein Production, and Pharmacology

Read more about the exciting research taking place at Pfizer La Jolla.

Pfizer Research at Rinat, San Francisco, California

Site Statistics:

  • State-of-the-art facility with specialized laboratories and equipment

Functions: Discovery, Protein Engineering and Biology

Primary Therapeutic Areas: Neurology, Oncology, Infectious Disease, and Cardiovascular, Metabolic and Endocrine disorders

Key Technologies: Protein-based Therapeutics

Read more about the exciting research taking place at Rinat.

For more information, visit the Research & Development section.

Pfizer Research at Groton, Connecticut

Site Statistics:

  • 160-acre site with 2.7-million-square-feet of state-of-the-art facility space at Groton — the largest pharmaceutical research facility of its kind in the world.
  • Groton is an integrated co-generation facility capable of supplying 100% of the site's annual energy requirements featuring renewable and green technologies such as photo-voltaic cells, on-site electric car charging stations, micro-turbines, and a low-emission gas turbine
  • The Groton site features over 250,000 square feet of ergonomically designed "Flexible Office" space capable of accommodating the needs of a mobile or fixed work force. The space is easily configurable and offers colleagues the opportunity to participate in a dynamic workspace to the degree of their liking as well as providing access to different types of space for specific needs such as video conferencing, teleconferencing, telepresence, and team meeting rooms.
  • The Clinical Research Unit (CRU), in New Haven, is a state-of-the-art research facility which provides comprehensive care in clinical studies. The CRU's cutting edge technology includes a biomarker laboratory and a research pharmacy.

Functions: Discovery, Biology, Clinical, and Medicinal Chemistry, Drug Metabolism, Pharmaceutical Sciences, Development, Animal Health, and Drug Effectiveness and Safety Evaluation

Key Technologies: Molecular Profiling, Primary Pharmacology Screening, Protein and Cellular Reagents, GeMM (Genetically Modified Models), Liquid Compound Management and Distribution, Reagent Antibody, Discovery High Throughput Screening, ADME (absorption, distribution, metabolism, excretion) Screening, Toxicity Screening and Safety Assessment, Biocatalysis, Microbiology, Developmental and Reproductive Toxicology, Safety Pharmacology, BioBank, Medicinal Chemistry, Structural Biology, Analytical Chemistry, Compound Safety Profiling, BioImaging, Electron Microscopy, Process Safety Screening, Continuous Processing, Materials Science, Active Ingredient and Formulation Development

Read more about Pfizer Connecticut Center of Discovery & Development Sciences.

For more information, visit the Research & Development section.

Pfizer Research at Cambridge, Massachusetts

Site Statistics:

  • The Cambridge and Andover campuses encompass 1.4 million square feet
  • In 2011, Pfizer Cambridge was honored with the Cambridge Chamber of Commerce's "Leading Edge Award", which recognizes a business that demonstrates leadership and innovation in the technology or biotechnology industries

Functions: Pharmaceutical and Biotherapeutic/biologics Research, Drug Metabolism, Biotechnology Units, Development, Medical, Oncology & Specialty Care Business Units

Primary Therapeutic Areas: Inflammation & Remodeling, Immunology & Autoimmunity, Orphan and Genetic Diseases, Cardiovascular Medicine and Neuroscience research

Key Technologies: Biological Technologies (Large Molecule Technologies), Synthetic & Medicinal Chemistry, Oligonucleotide Therapeutics (LNA, RNA), Genetics & Mathematical Modeling, ADME (absorption, distribution, metabolism, excretion and toxicity), Computational Sciences

Pfizer Research at Andover, Massachusetts

Site Statistics:

  • 70-acre site that combines state-of-the-art R&D facilities with flexible, multi-product manufacturing capabilities. Andover is strategically positioned as a fully integrated site, serving as a vital cog in both Pfizer's WRD and Pfizer Global Supply network
  • In 2007, Andover became the first biotechnology facility in New England to receive OSHA's Voluntary Protection Program (VPP) certification for its work in building a culture of safety

Functions: Drug Safety R&D (DSRD), BioTherapeutic Pharmaceutical Sciences: Bioprocess R&D (BRD), Analytical R&D (ARD), Pharmaceutical R&D (PhRD), Comparative Medicine (CM), Pharmocokinetics, Dynamics & Metabolism (PDM), Global Chemistry, Manufacturing and Controls (GCMC)

Primary Therapeutic Areas: Services multiple therapeutic areas; focused on biological compounds

The Andover campus consists of eight buildings which house laboratories, clinical and commercial manufacturing suites, purification and support areas. The manufacturing areas produce Coagulation Factor IX (Recombinant) and bone morphogenetic protein (rhBMP), which stimulates bone growth and is marketed in a drug-device combination known as Infuse.

Andover is the global production facility for polysaccharides, a component of Pneumococcal 13-valent Conjugate Vaccine (Diptheria CRM197 Protein), the company's vaccine for the prevention of invasive pneumococcal disease in infants and young children. Andover's Building B is approved as a multiproduct facility, allowing clinical and commercial products to be manufactured simultaneously.

For more information, visit the Research & Development section.

Pfizer Research at St. Louis, Missouri

Site Statistics:

  • Three locations containing 545,000-square-feet lab space and 90,000-square-feet office space

Functions: R&D: Pharm Science Biologics, Indications Discovery Research Unit

Key Technologies: BioTherapeutics Pharm Sciences Pilot Plant, Indications Discovery Research Unit

Read more about Pfizer St. Louis — the global center of emphasis for Biologics.

For more information, visit the Research & Development section.

Pfizer Research at Sandwich, UK

Functions: Pharmatherapeutics Pharmaceutical Sciences, International Regulatory Strategy; International Safety Strategy

Business Units: Primary Care

Key Technologies: Active Pharmaceutical Ingredient (API) Route Design, Development and Manufacturing; Analytical Science Drug Product Design and Development; Drug Product Manufacture; Regulatory Chemistry Manufacturing and Control (CMC) Strategy; Good Manufacturing Process (GMP) Quality Assurance; Materials Science

Pfizer Research at Cambridge, UK

Pfizer Neusentis Unit: Neusentis, part of Pfizer Limited, consolidates Pfizer's Pain & Sensory Disorders and Regenerative Medicine units into a new biotech like unit in Cambridge, UK. Over the past few years Pfizer has built world leading expertise in the field of ion channels. Neusentis scientists focus this expertise on delivering new medicines across all forms of pain influenced by this mechanism. Additionally, they explore opportunities across sensory disorders in which there is a strong mechanistic relationship to ion channels, such as auditory and visual disorders. With a number of potential medicines in the clinic the unit's colleagues are working hard to provide new therapies and treatment options for patients in pain.
 

Pharmaceutical Sciences, Devices Centre of Emphasis (DCoE): Pfizer's Device Centre of Excellence (DCoE) specialises in the design and development of drug delivery devices, such as injectors or inhalers. The DCoE group based at Cambridge, UK is responsible for the design of new devices, along with the testing and industrialisation. DCoE both develops internally and works with a wide array of external partners to achieve the optimum device design for Pfizer's drug delivery needs.
 

For more information, visit the Research & Development section.

Pfizer Research at Pearl River, NY

Site Statistics:

  • Pfizer Global Manufacturing: Specialty Care/Biotech and Consumer Healthcare
  • Pfizer Global Research and Development: Vaccine Research; Oncology Research Unit-East
  • 550-acre site in Rockland County, N.Y.
  • 2.5-million-square-feet under roof: 28 buildings, eight miles of roadway, five ponds
  • Products Manufactured: Prevnar® 7v and Prevnar 13™, Mylotarg®, and the Centrum® family of multivitamins for the U.S. market: Centrum®; Centrum® Silver®; Centrum Performance®; Centrum Cardio®, Centrum® Chewables, Centrum Kids®, Centrum Ultra Women's®

For more information, visit the Research & Development section.
Printable Version
 
 
Source URL: http://www.pfizer.com/research/rd_works/rd_locations